Business Daily Media

Men's Weekly

.

AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.

Multiple Institutions Give AIM a "Buy" Rating

HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to the U.S.

Food and Drug Administration (FDA). The vaccine has demonstrated significantly higher humoral and cellular immunity compared to internationally marketed products. If the product progresses smoothly, it will accelerate AIM Vaccine's international expansion and contribute to substantial performance growth.

In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly higher levels of specific IgG antibody titers, live-virus neutralizing antibody potency, and specific T-cell immunity compared to internationally marketed mRNA RSV control vaccines.

This announcement highlights AIM Vaccine's innovative capabilities and underscores the acceleration of its internationalization efforts, which have been recognized by multiple institutions.

Recently, FOSUN INTERNATIONAL SECURITIES initiated coverage of AIM Vaccine, assigning a "Buy" rating with a 12-month target price of HKD 11.0. The report cited the company's strong product pipeline, technological leadership, and potential for international growth as key factors. Similarly, SDICSI released a research report predicting that AIM Vaccine will launch 1-2 products annually over the next three years. If the products in development gain approval and progress smoothly in international markets, they are expected to drive new performance growth and expand market potential. SDICSI also assigned a "Buy" rating with a target price of HKD 9.5.

FOSUN INTERNATIONAL SECURITIES's analysis indicates that the Chinese vaccine market is evolving in line with global trends, where high-value products and leading companies dominate. With its differentiated advantages, AIM Vaccine is poised to secure a leading position in the domestic market while achieving scalable expansion internationally. Additionally, the company's comprehensive and iterative product portfolio is expected to enhance its market share, pricing power, and profitability, further supporting long-term growth.

The report also emphasized that AIM Vaccine, with its diversified product portfolio, technological strengths, and global expansion strategy, presents an attractive investment opportunity for investors. With a series of high-value products set to launch and profitability expected to rebound from 2025 onwards, the company is positioned for strong growth and potential valuation reassessment.

Globally, there are currently no approved antiviral drugs for RSV available for clinical use. Vaccination for active immune prophylaxis remains the most effective means to prevent severe RSV infections. No RSV vaccines have been approved for marketing in PRC. In 2023, global sales of RSV vaccines reached USD 2.46 billion, and according to industry consultants, the market size is expected to grow to approximately USD 16.7 billion by 2030.

The mRNA vaccine field is still wide open with plenty of opportunities, as there are few competitors globally. AIM Vaccine is one of the earliest companies in PRC to develop mRNA vaccine products and is among the first domestic vaccine enterprises to obtain independent patents for mRNA technology. The company has established a mature mRNA vaccine R&D system and has developed multiple mRNA candidate vaccines, including vaccines for shingles, rabies, and influenza, in addition to the mRNA RSV vaccine.
Hashtag: #AIMVaccine

The issuer is solely responsible for the content of this announcement.

News from Asia

AUX Commences Trading on Hong Kong Stock Exchange, Launching New Chapter in Global Growth

HONG KONG SAR - Media OutReach Newswire - 10 September 2025 - AUX Electric Co., Ltd. (Stock Code: 2580.HK), the core air conditioning business of AUX Group, listed on the Hong Kong Stock Exchange ...

BeOne Medicines Honored with the Global Oncology Innovation Leadership Award at BIOHK 2025, Supporting "1+" to Accelerate the Delivery of Innovative Cancer Therapies

HONG KONG SAR - Media OutReach Newswire - 11 September 2025 - BeOne Medicines (BeOne)(NASDAQ: ONC; HKEX: 06160; SSE: 688235), was honored today at BIOHK 2025, the Hong Kong International Biotechno...

Gree Showcases Photovoltaic DC Air Conditioning System at Gree Summit Partner, Positioning Singapore as Green Innovation Hub

SINGAPORE - Media OutReach Newswire - 11 September 2025 - Singapore has long been recognized as a pivotal hub in Gree's Southeast Asia growth strategy. With its advanced infrastructure, strong sus...

TIYA Conference 2025: Over 150 Youth Leaders from 15 Countries Gathered to Advance United Nations’ SDGs

Three-day conference in Singapore empowers young changemakers through mentorship and international collaborationSINGAPORE - Media OutReach Newswire - 11 September 2025 - Tzu-Chi Foundation (Singap...

Finex Collaborates with Sharing Happiness to Honor Indonesian Veterans

JAKARTA, INDONESIA - Media OutReach Newswire - 11 September 2025 - Finex, an acclaimed Indonesian broker, and Sharing Happiness, a charity organization, partnered to honor the members of the Indo...

Momcozy Honored at Kind+Jugend 2025 for Innovation in Maternal Care

COLOGNE, GERMANY - Media OutReach Newswire - 11 September 2025 - Momcozy, a global leader in maternal care and a pioneer of the Mom-First philosophy, announced at Kind+Jugend that its Ergonest M...

Australian representation at CIFTIS reflects deepening cooperation with China: experts

BEIJING, CHINA - Media OutReach Newswire - 11 September 2025 - The 2025 China International Fair for Trade in Services (CIFTIS) reflects the deepening cooperation between China and Australia in se...

Holding High the Banner of Opening-up and Leading Trade in Services, Beijing Is Setting a New Benchmark for Opening up the Chinese Services Sector: Through the Lens of CIFTIS

BEIJING, CHINA - Media OutReach Newswire - 11 September 2025 - On September 10, the 2025 China International Fair for Trade in Services (CIFTIS), themed "Embrace Intelligent Technologies, Empower ...

Chinese services trade fair draws global participation, highlights open markets

BEIJING, CHINA - Media OutReach Newswire - 11 September 2025 - Against the backdrop of repurposed blast furnaces and industrial relics of Shougang Park in western Beijing, the 2025 China Internati...

Services trade fair shows China's continued commitment to opening up, expert says

BEIJING, CHINA - Media OutReach Newswire - 11 September 2025 - The 2025 China International Fair for Trade in Services underscores China's commitment to high-level opening-up, according to one exp...

AWS research shows strong AI adoption momentum in Australia, with startups outpacing large enterprises in innovation

Amazon Web Services (AWS), an Amazon.com company, released new research revealing that while artificial intelligence (AI) adoption continues to acce...

Changing the World One Bite At a Time: IKU Turns 40

One of Australia’s first plant-based, chef-led eateries and now ready meal provider IKU is celebrating its 40 year anniversary with the business e...

Three generations marking 45 years in hot-air balloons

Australia’s leading hot-air balloon company is celebrating 45 years in the sky and its 700,000th passenger, driven by the passion of father-son du...

Workplace DMs, Reinvented: Deputy Messaging, Purpose-Built For Shift-Based Teams

Deputy, the global people platform for shift-based businesses, has launched Deputy Messaging, a fully integrated, real-time communication tool designe...

Revolutionizing Fulfillment: How Virtual Warehousing is Changing the Game?

The e-commerce landscape is evolving more rapidly than ever, and the way businesses are managing their fulfillment is also revolutionizing. At the...

SME lender Dynamoney welcomes new CEO, Brett Thomas

Strengthens growth ambitions and signals expanded offering Dynamoney, a leading commercial finance provider for Australian SMEs,  has today appoint...

Sell by LayBy